Abstract
We examined insulin action/secretion and cardiovascular disease risk factors in Japanese subjects with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) who were not taking any medications known to affect glucose tolerance, blood pressure (BP) or plasma lipids (PLs). A total of 1,399 subjects received measurements of anthropometry, BP, PLs, and plasma glucose/insulin concentrations during 75 g-oral glucose tolerance test (OGTT). According to 2003 American Diabetes Association criteria, subjects were classified as having normal fasting glucose (NFG)/normal glucose tolerance (NGT) (n=1,173), IFG (n=128), IGT (n=55), and IFG/IGT (n=43). Insulin action was calculated using the HOMA-R (index of hepatic insulin resistance) and Matsuda index (reflects whole body insulin sensitivity). The ratio of the incremental area under the curve of insulin to that of glucose during OGTT (ΔAUCPI/ΔAUCPG) was used as an index of β-cell function. HOMA-R was higher in IFG (2.3±0.1) and IFG/IGT (2.5±0.2) than in NFG/NGT (1.8±0.03). The Matsuda index was lower in IFG (6.5±0.3), IGT (5.4±0.4) and IFG/IGT (5.1±0.5) than in NFG/NGT (9.6±0.2). ΔAUCPI/ΔAUCPG was lower in IGT (0.6±0.05) and IFG/IGT (0.5±0.05) than in IFG (1.4±0.12) or NFG/NGT (1.2±0.03). Mean BP was higher in IGT (100±1.7 mmHg) than in NFG/NGT (91±0.3) or IFG (95±1.1). The plasma triglyceride level was higher in IGT (155±14 mg/dL) and IGT/IFG (173±12) than in IFG (132±7) or NFG/NGT (122±2). In conclusion, 1) whole body insulin sensitivity is decreased in IFG and IGT, with a greater reduction in IGT, 2) hepatic insulin resistance and preserved β-cell function are characteristics of IFG, and 3) higher BP and triglyceride levels are observed in IGT. IGT is more closely associated with risk factors for cardiovascular disease than is IFG.
Similar content being viewed by others
Article PDF
References
Unwin N, Shaw J, Zimmet P, Alberti KGMM : Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med 2002; 19: 708–723.
Shaw J, Zimmet P, de Courten M, et al: Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes in Mauritius? Diabetes Care 1999; 22: 399–402.
Gabir MM, Hanson R, Dabelea D, et al: Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 2000; 23: 1113–1118.
de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ : The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care 1998; 21: 1686–1690.
Eschwège E, Charles MA, Simon D, Thibult N, Balkau B : Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study. Diabetes Care 2001; 24: 1941–1944.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus : Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197.
Dunstan D, Zimmet P, Welborn T, et al: The rising prevalence of diabetes mellitus and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 5: 829–834.
Larsson H, Berglund G, Lindgarde F, Ahren B : Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance. Diabetologia 1998; 41: 1124–1125.
Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS : Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980−1985 World Health Organization diagnostic criteria. Diabetes Care 1997; 20: 1859–1862.
Ko GT, Chan JC, Woo J, Cockram CS : Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population. Diabetes Care 1998; 21: 2094–2097.
The DECODE Study Group : Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617–621.
Tripathy D, Carlsson M, Almgren P, et al: Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 2000; 49: 975–980.
Guerrero-Romero F, Rodríguez-Moraán M : Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose. J Diabetes Complications 2001; 15: 34–37.
Weyer C, Bogardus C, Mott DM, Pratley RE : The natural history of insulin secretory disfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104: 787–794.
Haeften TWV, Pimenta W, Mitrakou A, et al: Disturbance in β cell function in impaired fasting glycemia. Diabetes 2002; 51 ( Suppl 1): S265–S270.
Ferrannini E, Gastaldelli A, Miyazaki Y, et al: Predominant role of reduced beta-cell sensitivity to glucose over insulin sensitivity in impaired glucose tolerance. Diabetologia 2003; 46: 1211–1219.
Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T : Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose, the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 2003; 26: 868–874.
Pimenta WP, Santos ML, Cruz NS, Aragon FF, Padovani CR,, Gerich JE : Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion. Diabetes Metab 2002; 28: 468–476.
Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA, the San Antonio Metabolism Study: Betacell dysfunction and glucose intolerance: results from the San Antonio Metabolism (SAM) study. Diabetologia 2003; 47: 31–39.
Schianca GPC, Rossi A, Sainaghi PP, Maduli E, Bartoli E : The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care 2003; 26: 1333–1337.
Weyer C, Bogardus C, Pratley R : Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 1999; 48: 2197–2203.
Festa A, D'Agostino R, Hanley A, Karter AJ, Saad MF, Haffner SM : Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004; 53: 1549–1555.
Davies MJ, Raymond NT, Day JL, Hales CN, Burden AC : Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med 2000; 17: 433–440.
Conget I, Fernadez Real JM, Costa A, Casamitjana R, Ricart W : Insulin secretion and insulin sensitivity in relation to glucose tolerance in a group of subjects at a high risk for type 2 diabetes mellitus. Med Clin 2001; 116: 491–492.
Genuth S, Alberti KG, Bennet P, et al, The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus : Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–3167.
Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA : Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 2003; 26: 3160–3167.
Kawamori R : Insulin resistance seen in non-insulin dependent diabetes mellitus and hypertension. Hypertens Res 1996; 19 ( Suppl 1): S61–S64.
Rathmann W, Giani G, Mielck A : Cardiovascular risk factors in newly diagnosed abnormal glucose tolerance: comparison of 1997 ADA and 1985 WHO criteria. Diabetologia 1999; 42: 1268–1269 Letter.
Hanefield M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C : Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 1999; 16: 212–218.
The DECODE Study Group, the European Diabetes Epidemiology Group : Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 16: 397–404.
The DECODE Study Group on behalf of the European Diabetes Epidemiology Group : Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascuar and noncardiovascular diseases? Diabetes Care 2003; 26: 688–696.
Tanaka S, Hayase A, Hashimoto A, et al: Hypertension and cardiovascular diseases in an epidemiological study in Hokkaido, Japan. J Cardiovasc Pharmacol 1990; 16 ( Suppl 7): S83–S86.
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R : Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Matsuda M, DeFronzo RA : Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic glucose clamp. Diabetes Care 1999; 22: 1462–1470.
Drivsholm T, Hansen T, Urhammer SA, et al: Assessment of insulin sensitivity and beta-cell function from an oral glucose tolerance test. Diabetologia 1999; 42 ( Suppl 1): A185.
DeFronzo RA, Ferrannini E, Simonson DC : Fasting hyperglycemia in non−insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989; 38: 387–395.
Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD : Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 1998; 47: 523–529.
De Pablos-Velasco PL, Martinez Marin FJ, Rodriguez Perez F, Ania BJ, Losada A, Betancor P : Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population: comparison of the 1997 ADA and the 1995 WHO criteria: the Guia study. Diabet Med 2001; 18: 235–241.
Larsson H, Berglund G, Lindgärde F, Ahrén B : Comparison of ADA and WHO criteria for the diagnosis of diabetes and glucose intolerance. Diabetologia 1998; 41: 1124–1125.
Pallardo LF, Herranz L, Martin-Vaquero P, Garcia-Ingelmo T, Grande C, Janez M : Impaired fasting glucose and impaired glucose tolerance in women with prior gestational diabetes are associated with a different cardiovascular profile. Diabetes Care 2003; 26: 2318–2322.
Kim SH, Chunawala L, Linde R, Reaven GM : Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice. J Am Coll Cardiol 2006; 48: 293–297.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miyazaki, Y., Akasaka, H., Ohnishi, T. et al. Differences in Insulin Action and Secretion, Plasma Lipids and Blood Pressure Levels between Impaired Fasting Glucose and Impaired Glucose Tolerance in Japanese Subjects. Hypertens Res 31, 1357–1363 (2008). https://doi.org/10.1291/hypres.31.1357
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1357
Keywords
This article is cited by
-
Effect of adiposity on insulin action after acute and chronic resistance exercise in non-diabetic women
European Journal of Applied Physiology (2013)